Telebionix is a MedTech innovation company based in California with a clear mission encapsulated in its slogan, "Saving Lives Through Innovation." Founded in 2020, the company is committed to revolutionizing the future of healthcare by developing smart, AI-driven, and easy-to-use remote devices that enable broader access to quality care. The company is not only focused on providing healthcare accessibility to the elderly and individuals with limited mobility but also aims to serve remote and underserved communities globally. Their flagship product, Remosense, offers accurate and repeatable monitoring of vital signs, including heart rate, blood pressure, body temperature, blood oxygenation, heart rate variability, and even lung and heart sounds via an AI-driven stethoscope. The recent Pre Seed Round investment in February 2022 from Steamwork Ventures signifies a promising endorsement of Telebionix's potential to revolutionize the healthcare industry. With a focus on proactive, predictive, reliable, and transformative healthcare, Telebionix is poised to make profound impacts on patient outcomes and the overall quality of life. For more insight, check out the video introducing their innovative solutions.
No recent news or press coverage available for Telebionix.